G
Giulia Di Lazzaro
Researcher at University of Rome Tor Vergata
Publications - 46
Citations - 892
Giulia Di Lazzaro is an academic researcher from University of Rome Tor Vergata. The author has contributed to research in topics: Medicine & Parkinson's disease. The author has an hindex of 13, co-authored 39 publications receiving 475 citations. Previous affiliations of Giulia Di Lazzaro include UCL Institute of Neurology.
Papers
More filters
Journal ArticleDOI
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
Paraskevi Krashia,Alberto Cordella,Annalisa Nobili,Livia La Barbera,Mauro Federici,Alessandro Leuti,Federica Campanelli,Giuseppina Natale,Gioia Marino,Valeria Calabrese,Francescangelo Vedele,Veronica Ghiglieri,Barbara Picconi,Giulia Di Lazzaro,Tommaso Schirinzi,Giulia Maria Sancesario,Nicolas Casadei,Olaf Riess,Sergio Bernardini,Antonio Pisani,Paolo Calabresi,Maria Teresa Viscomi,Charles N. Serhan,Valerio Chiurchiù,Marcello D'Amelio,Nicola Biagio Mercuri +25 more
TL;DR: Rats overexpressing human α-synuclein show defects in dopamine signalling before dopamine cell loss, and that this is associated with low Resolvin D1 levels and neuroinflammation, suggesting there is an imbalance between neuroinflammatory and pro-resolving processes in PD.
Journal ArticleDOI
Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence.
Tommaso Schirinzi,Giuseppina Martella,Paola Imbriani,Giulia Di Lazzaro,Donatella Franco,Vito Luigi Colona,Mohammad Alwardat,Paola Sinibaldi Salimei,Nicola Biagio Mercuri,Mariangela Pierantozzi,Antonio Pisani +10 more
TL;DR: Clinical and experimental findings suggest that Vitamin E could be a potential, useful agent for Parkinson's disease patients, and data, although preliminary, may encourage future confirmatory trials.
Journal ArticleDOI
Systemic activation of Nrf2 pathway in Parkinson's disease
Sara Petrillo,Tommaso Schirinzi,Tommaso Schirinzi,Giulia Di Lazzaro,Jessica D’Amico,Vito Luigi Colona,Enrico Bertini,Mariangela Pierantozzi,Luisa Mari,Nicola Biagio Mercuri,Fiorella Piemonte,Antonio Pisani +11 more
TL;DR: Preclinical studies underlined the relevance of Nuclear factor erythroid 2‐related factor 2 (Nrf2) transcription factor pathway in the pathogenesis of Parkinson's disease (PD).
Journal ArticleDOI
Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy.
Tommaso Schirinzi,Rocco Cerroni,Giulia Di Lazzaro,Claudio Liguori,Simona Scalise,Roberta Bovenzi,Matteo Conti,Elena Garasto,Nicola Biagio Mercuri,Mariangela Pierantozzi,Antonio Pisani,Alessandro Stefani +11 more
TL;DR: The analysis suggests that PD patients’ needs during COVID-19 emergency include appropriate and complete information, a timely update on changes in clinical services, and the continuity of care, even in a remote mode.
Journal ArticleDOI
Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease.
Tommaso Schirinzi,Francesco Di Lorenzo,Giulia Maria Sancesario,Giulia Di Lazzaro,Viviana Ponzo,Antonio Pisani,Nicola Biagio Mercuri,Giacomo Koch,Alessandro Martorana +8 more
TL;DR: The association of motor disturbances with low Aβ42 CSF levels and individual SAI suggests that amyloid-mediated degeneration of cholinergic system may account for early AD-related motor impairment, providing interesting insights either for frailty stratification of patients or personalized therapies.